Metlife (NYSE:MET) had its price objective raised by Morgan Stanley from $46.00 to $47.00 in a research report issued to clients and investors on Tuesday, Benzinga reports. The firm presently has an “overweight” rating on the financial services provider’s stock. Morgan Stanley’s price objective points to a potential upside of […]